PT1265914E - Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos - Google Patents

Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos Download PDF

Info

Publication number
PT1265914E
PT1265914E PT01920759T PT01920759T PT1265914E PT 1265914 E PT1265914 E PT 1265914E PT 01920759 T PT01920759 T PT 01920759T PT 01920759 T PT01920759 T PT 01920759T PT 1265914 E PT1265914 E PT 1265914E
Authority
PT
Portugal
Prior art keywords
wnt
same
nucleic acids
acids encoding
related polypeptides
Prior art date
Application number
PT01920759T
Other languages
English (en)
Inventor
Diane Pennica
Luca K Rastelli
Original Assignee
Geneprint Inc
Curagen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geneprint Inc, Curagen Corp filed Critical Geneprint Inc
Publication of PT1265914E publication Critical patent/PT1265914E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/07Animals genetically altered by homologous recombination
    • A01K2217/075Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Seasonings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT01920759T 2000-03-22 2001-03-22 Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos PT1265914E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19125800P 2000-03-22 2000-03-22

Publications (1)

Publication Number Publication Date
PT1265914E true PT1265914E (pt) 2008-04-08

Family

ID=38885296

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01920759T PT1265914E (pt) 2000-03-22 2001-03-22 Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos

Country Status (11)

Country Link
US (3) US20020098540A1 (pt)
EP (1) EP1265914B1 (pt)
JP (1) JP2003527849A (pt)
AT (1) ATE382055T1 (pt)
AU (2) AU2001247781C1 (pt)
CA (1) CA2404216A1 (pt)
DE (1) DE60132075T2 (pt)
DK (1) DK1265914T3 (pt)
ES (1) ES2298226T3 (pt)
PT (1) PT1265914E (pt)
WO (1) WO2001070775A2 (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114644D0 (en) * 2001-06-15 2001-08-08 Oxford Glycosciences Uk Ltd Protein
AU2003227504A1 (en) 2002-04-15 2003-10-27 Chugai Seiyaku Kabushiki Kaisha METHOD OF CONSTRUCTING scDb LIBRARY
WO2004065611A1 (ja) 2003-01-21 2004-08-05 Chugai Seiyaku Kabushiki Kaisha 抗体の軽鎖スクリーニング方法
JP4794301B2 (ja) 2003-06-11 2011-10-19 中外製薬株式会社 抗体の製造方法
AU2003280713A1 (en) * 2003-11-04 2005-05-19 Chugai Seiyaku Kabushiki Kaisha Process for producing antibody
US20050251054A1 (en) * 2004-05-10 2005-11-10 Medpond, Llc Method and apparatus for measurement of autonomic nervous system function
EP3050963B1 (en) 2005-03-31 2019-09-18 Chugai Seiyaku Kabushiki Kaisha Process for production of polypeptide by regulation of assembly
EP1870458B1 (en) 2005-03-31 2018-05-09 Chugai Seiyaku Kabushiki Kaisha sc(Fv)2 STRUCTURAL ISOMERS
CN101262885B (zh) 2005-06-10 2015-04-01 中外制药株式会社 含有sc(Fv)2的药物组合物
KR101367544B1 (ko) 2005-06-10 2014-02-26 추가이 세이야쿠 가부시키가이샤 메글루민을 함유하는 단백질 제제의 안정화제, 및 그의이용
ES2654040T3 (es) 2006-03-31 2018-02-12 Chugai Seiyaku Kabushiki Kaisha Método de modificación de anticuerpos para la purificación de anticuerpos biespecíficos
CN102245760A (zh) 2008-07-07 2011-11-16 牛津纳米孔技术有限公司 酶-孔构建体
CA2730068A1 (en) 2008-07-07 2010-01-14 Oxford Nanopore Technologies Limited Base-detecting pore
GB0820927D0 (en) 2008-11-14 2008-12-24 Isis Innovation Method
CN102482330A (zh) * 2009-01-30 2012-05-30 牛津纳米孔技术有限公司 酶突变体
CA2750879C (en) 2009-01-30 2018-05-22 Oxford Nanopore Technologies Limited Adaptors for nucleic acid constructs in transmembrane sequencing
GB0905140D0 (en) 2009-03-25 2009-05-06 Isis Innovation Method
KR101939420B1 (ko) 2011-02-11 2019-01-16 옥스포드 나노포어 테크놀로지즈 리미티드 돌연변이체 세공
KR20140050067A (ko) 2011-07-25 2014-04-28 옥스포드 나노포어 테크놀로지즈 리미티드 막횡단 포어를 사용한 이중 가닥 폴리뉴클레오티드 서열분석을 위한 헤어핀 루프 방법
JP6271505B2 (ja) 2012-04-10 2018-01-31 オックスフォード ナノポール テクノロジーズ リミテッド 変異体ライセニンポア
WO2014013259A1 (en) 2012-07-19 2014-01-23 Oxford Nanopore Technologies Limited Ssb method
GB201314695D0 (en) 2013-08-16 2013-10-02 Oxford Nanopore Tech Ltd Method
CN105209634B (zh) 2013-03-08 2020-05-12 牛津纳米孔技术公司 酶停滞方法
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
EP3050896B1 (en) 2013-09-27 2021-07-07 Chugai Seiyaku Kabushiki Kaisha Method for producing polypeptide heteromultimer
GB201403096D0 (en) 2014-02-21 2014-04-09 Oxford Nanopore Tech Ltd Sample preparation method
CN106459159B (zh) 2014-05-02 2021-11-30 牛津纳米孔技术公司 突变孔
CN114605507A (zh) 2014-09-01 2022-06-10 弗拉芒区生物技术研究所 突变csgg孔
US10266885B2 (en) 2014-10-07 2019-04-23 Oxford Nanopore Technologies Ltd. Mutant pores
GB201418159D0 (en) 2014-10-14 2014-11-26 Oxford Nanopore Tech Ltd Method
WO2017115773A1 (ja) 2015-12-28 2017-07-06 中外製薬株式会社 Fc領域含有ポリペプチドの精製を効率化するための方法
GB201609220D0 (en) 2016-05-25 2016-07-06 Oxford Nanopore Tech Ltd Method
GB201807793D0 (en) 2018-05-14 2018-06-27 Oxford Nanopore Tech Ltd Method
CN114457052B (zh) * 2021-09-17 2024-02-27 厦门大学 一种抗肿瘤的多肽组合物及其应用

Also Published As

Publication number Publication date
AU4778101A (en) 2001-10-03
US20080206252A1 (en) 2008-08-28
ES2298226T3 (es) 2008-05-16
US20020098540A1 (en) 2002-07-25
EP1265914B1 (en) 2007-12-26
AU2001247781C1 (en) 2006-08-17
US20050159373A1 (en) 2005-07-21
WO2001070775A2 (en) 2001-09-27
ATE382055T1 (de) 2008-01-15
DK1265914T3 (da) 2008-03-10
CA2404216A1 (en) 2001-09-27
AU2001247781B2 (en) 2006-02-02
EP1265914A2 (en) 2002-12-18
DE60132075T2 (de) 2009-03-12
WO2001070775A3 (en) 2002-01-10
DE60132075D1 (de) 2008-02-07
JP2003527849A (ja) 2003-09-24

Similar Documents

Publication Publication Date Title
PT1265914E (pt) Polipéptidos relacionados com wnt-1 e ácidos nucleicos que codificam estes polipéptidos
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
HK1013847A1 (en) Gdf-1 and uog-1 proteins
DE69838143D1 (de) Antimikrobielle peptide
NZ335485A (en) Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
GB9823897D0 (en) Immunotherapeutic methods and molecules
EP0258411A4 (en) DNA ENCODING STREPTAVIDINE, STREPTAVIDINE PRODUCED FROM IT, FUSED POLYPEPTIDES WITH AMINO ACID SEQUENCES FROM STREPTAVIDINE AND USES.
WO2002016418A3 (en) An iap binding peptide or polypeptide and methods of using the same
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
ATE357526T1 (de) Modifizierte hcv peptid-impfstoffe
WO2003016342A3 (en) Tumor antigens for prevention and/or treatment of cancer
EP1117682A4 (en) NEW PEPTIDES
GB9416536D0 (en) Orphan receptor
WO2001098355A3 (en) Cgi-69 compositions and methods of use
WO2001070808A3 (en) Angiogenesis - associated proteins, and nucleic acids encoding the same
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
EP0723016A3 (en) Leukocyte activation factor
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
DE69831584D1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
ATE293163T1 (de) Cyclin e spezifische konstrukte und komplexe
WO1999031256A3 (en) Cathepsin dc proteins, dna encoding the proteins, and their use in human cancer prognosis
WO2002097036A3 (en) Compositions and methods for adipose abundant protein
WO2002096355A3 (en) Compositions and methods for adipose abundant protein
HUP0001462A2 (en) Human toll-like receptor proteins, related reagents and methods